Fundz

Lario Therapeutics has been awarded $2.4 million in grant funding from The Michael J. Fox Foundation and Wellcome to expand its neuronal calcium channel platform for CNS disorders.

PRIVATEFeb 19, 2026

Amount Raised

$2.4 Million

Round Type

Grant

City Of EdinburghBiotechnologyHealth CareTherapeutics

Description

Lario Therapeutics received a total of $2.4 million in grant funding to support its drug discovery platform. The funding includes a $1.5 million grant from The Michael J. Fox Foundation and a $900k grant from Wellcome. This will further their work on Parkinson's disease and post-traumatic stress disorder (PTSD)

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Lario Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Sonire Therapeutics raised $18M (Series A) on March 31, 2026.
  • TippingPoint Biosciences raised $4.5M (Seed) on March 31, 2026.
  • Denali Therapeutics raised $200M (Debt Financing) on March 31, 2026.
  • Oncomatryx Biopharma raised $67M (Corporate Round) on March 30, 2026.
  • Marvel Biosciences raised $476K (Grant) on March 30, 2026.
  • Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.

Who to call at Lario Therapeutics, and when

A new round usually means Lario Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lario Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lario Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lario Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lario Therapeutics

Location

City Of Edinburgh, Scotland, United Kingdom

About

Lario Therapeutics is a biopharmaceutical company focused on developing first-in-class precision medicines for neurologic and epileptic disorders. Founded in 2021, Lario aims to translate human genetics and neuronal biology into effective treatments for severe neurological diseases. The company is particularly known for its work on selective small-molecule inhibitors of voltage-gated calcium channels. Lario is backed by major funding from respected organizations to expand its innovative drug discovery platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lario Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Lario Therapeutics's next move

See what Strategic adds

Lario Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.